Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. | Academic Article |
Why?
|
| Morphea and its variants and the "floating sign"-an additional finding in morphea. | Academic Article |
Why?
|
| Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib. | Academic Article |
Why?
|
| Morphea-like tattoo reaction. | Academic Article |
Why?
|
| Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis. | Academic Article |
Why?
|
| Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature. | Academic Article |
Why?
|
| Morphea | Academic Article |
Why?
|
| A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis. | Academic Article |
Why?
|
| Acute lipodermatosclerosis is associated with venous insufficiency. | Academic Article |
Why?
|
| Alopecia with perineural lymphocytes: a clue to linear scleroderma en coup de sabre. | Academic Article |
Why?
|
| Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits. | Academic Article |
Why?
|
| Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. | Academic Article |
Why?
|
| D-penicillamine in the treatment of localized scleroderma. | Academic Article |
Why?
|
| Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients. | Academic Article |
Why?
|
| Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. | Academic Article |
Why?
|